Presystemic Extraction: Mechanisms and Consequences
- 1 July 1993
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 33 (7) , 650-656
- https://doi.org/10.1002/j.1552-4604.1993.tb04719.x
Abstract
Many drugs have incomplete systemic availability after oral dosage. This can be attributed to incomplete absorption from the gastrointestinal tract, or to presystemic extraction, in which a fraction of an orally administered dose is biotransformed before reaching the systemic circulation. Presystemic extraction can occur either via biotransformation by gastrointestinal mucosa or enteric flora, or via metabolism during the “first‐pass” through the liver. For drugs with low oral bioavailability due to high presystemic extraction, impaired clearance leads to increased peak plasma levels and greater area under the concentration‐time curve, but minimal change in elimination half‐life.Keywords
This publication has 32 references indexed in Scilit:
- Sensitivity to Triazolam in the ElderlyNew England Journal of Medicine, 1991
- Hepatic Drug Metabolism and AgingClinical Pharmacokinetics, 1990
- Drug metabolism in the elderlyPharmacology & Therapeutics, 1988
- First-Pass EliminationClinical Pharmacokinetics, 1984
- Drug Administration in Hepatic DiseaseNew England Journal of Medicine, 1983
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982
- Drug Metabolism by the Gastrointestinal MucosaClinical Pharmacokinetics, 1981
- Hepatic First-pass Metabolism in Liver DiseaseClinical Pharmacokinetics, 1979
- Bioavailability of DrugsClinical Pharmacokinetics, 1976
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973